SXI Life Sciences
6.905,90
PKT
+48,39
PKT
+0,71
%
Werbung
Analysen zu SXI Life Sciences-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 20.01.06 | Novartis overweight | Prudential Financial | |
| 18.01.06 | Novartis kaufen | Helaba Trust | |
| 19.01.06 | Novartis neutral | JP Morgan | |
| 17.01.06 | Novartis buy | Merrill Lynch | |
| 20.01.06 | Novartis buy | Jyske Bank | |
| 13.01.06 | Novartis kaufen | DZ-Bank | |
| 17.01.06 | Novartis outperform | HypoVereinsbank | |
| 10.01.06 | Kuros (Kuros Biosciences) spekulativ kaufen | Biotech-Report | |
| 06.01.06 | Novartis kaufen | DZ-Bank | |
| 23.12.05 | Novartis kaufen | DZ-Bank | |
| 23.12.05 | Novartis | Weberbank | |
| 20.12.05 | Novartis halten | Pacific Continental Sec. | |
| 16.12.05 | Novartis | DZ-Bank | |
| 16.12.05 | Novartis halten | National-Bank AG | |
| 20.12.05 | Novartis buy | Jyske Bank | |
| 14.12.05 | Lonza halten | Hamburger Sparkasse | |
| 09.12.05 | Novartis | DZ-Bank | |
| 02.12.05 | Novartis | DZ-Bank | |
| 28.11.05 | Novartis | DZ-Bank | |
| 18.11.05 | Novartis | DZ-Bank | |
| 17.11.05 | Novartis | JRC | |
| 15.11.05 | Novartis | DZ-Bank | |
| 10.11.05 | Novartis | Zürcher Kantonalbank | |
| 09.11.05 | Novartis overweight | Lehman Brothers | |
| 08.11.05 | Novartis buy | Jyske Bank | |
| 04.11.05 | Novartis buy | Jefferies & Co | |
| 03.11.05 | Novartis Buy | Jefferies & Co | |
| 28.10.05 | Novartis | DZ-Bank | |
| 28.10.05 | Novartis kaufen | Berenberg Bank | |
| 28.10.05 | Novartis | Wirtschaftswoche | |
| 26.10.05 | Novartis Hold | Deutsche Securities | |
| 21.10.05 | Novartis | DZ-Bank | |
| 21.10.05 | Novartis akkumulieren | Independent Research | |
| 20.10.05 | Novartis buy | Merrill Lynch | |
| 19.10.05 | Novartis outperform | Goldman Sachs | |
| 19.10.05 | Novartis overweight | Lehman Brothers | |
| 20.10.05 | Novartis kaufen | Hamburger Sparkasse | |
| 19.10.05 | Novartis Outperform | Goldman Sachs | |
| 18.10.05 | Novartis neutral | Banc of America Sec. | |
| 19.10.05 | Novartis kaufen | Helaba Trust |